Cargando…

Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells

Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effects on multiple tissues, including the kidney. Here we have compared renal differentiation of iPS cells from healthy and BBS donors. High content image analysis of WT1-expressing kidney progenitors showed that cell proliferation, diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, James, Hurling, Chloe, Munir, Sabrina, Harley, Peter, Machado, Carolina Barcellos, Cujba, Ana-Maria, Alvarez-Fallas, Mario, Danovi, Davide, Lieberam, Ivo, Sancho, Rocio, Beales, Philip, Watt, Fiona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272764/
https://www.ncbi.nlm.nih.gov/pubmed/37333983
http://dx.doi.org/10.3389/fcell.2023.1163825
_version_ 1785059569357029376
author Williams, James
Hurling, Chloe
Munir, Sabrina
Harley, Peter
Machado, Carolina Barcellos
Cujba, Ana-Maria
Alvarez-Fallas, Mario
Danovi, Davide
Lieberam, Ivo
Sancho, Rocio
Beales, Philip
Watt, Fiona M.
author_facet Williams, James
Hurling, Chloe
Munir, Sabrina
Harley, Peter
Machado, Carolina Barcellos
Cujba, Ana-Maria
Alvarez-Fallas, Mario
Danovi, Davide
Lieberam, Ivo
Sancho, Rocio
Beales, Philip
Watt, Fiona M.
author_sort Williams, James
collection PubMed
description Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effects on multiple tissues, including the kidney. Here we have compared renal differentiation of iPS cells from healthy and BBS donors. High content image analysis of WT1-expressing kidney progenitors showed that cell proliferation, differentiation and cell shape were similar in healthy, BBS1, BBS2, and BBS10 mutant lines. We then examined three patient lines with BBS10 mutations in a 3D kidney organoid system. The line with the most deleterious mutation, with low BBS10 expression, expressed kidney marker genes but failed to generate 3D organoids. The other two patient lines expressed near normal levels of BBS10 mRNA and generated multiple kidney lineages within organoids when examined at day 20 of organoid differentiation. However, on prolonged culture (day 27) the proximal tubule compartment degenerated. Introducing wild type BBS10 into the most severely affected patient line restored organoid formation, whereas CRISPR-mediated generation of a truncating BBS10 mutation in a healthy line resulted in failure to generate organoids. Our findings provide a basis for further mechanistic studies of the role of BBS10 in the kidney.
format Online
Article
Text
id pubmed-10272764
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102727642023-06-17 Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells Williams, James Hurling, Chloe Munir, Sabrina Harley, Peter Machado, Carolina Barcellos Cujba, Ana-Maria Alvarez-Fallas, Mario Danovi, Davide Lieberam, Ivo Sancho, Rocio Beales, Philip Watt, Fiona M. Front Cell Dev Biol Cell and Developmental Biology Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effects on multiple tissues, including the kidney. Here we have compared renal differentiation of iPS cells from healthy and BBS donors. High content image analysis of WT1-expressing kidney progenitors showed that cell proliferation, differentiation and cell shape were similar in healthy, BBS1, BBS2, and BBS10 mutant lines. We then examined three patient lines with BBS10 mutations in a 3D kidney organoid system. The line with the most deleterious mutation, with low BBS10 expression, expressed kidney marker genes but failed to generate 3D organoids. The other two patient lines expressed near normal levels of BBS10 mRNA and generated multiple kidney lineages within organoids when examined at day 20 of organoid differentiation. However, on prolonged culture (day 27) the proximal tubule compartment degenerated. Introducing wild type BBS10 into the most severely affected patient line restored organoid formation, whereas CRISPR-mediated generation of a truncating BBS10 mutation in a healthy line resulted in failure to generate organoids. Our findings provide a basis for further mechanistic studies of the role of BBS10 in the kidney. Frontiers Media S.A. 2023-06-02 /pmc/articles/PMC10272764/ /pubmed/37333983 http://dx.doi.org/10.3389/fcell.2023.1163825 Text en Copyright © 2023 Williams, Hurling, Munir, Harley, Machado, Cujba, Alvarez-Fallas, Danovi, Lieberam, Sancho, Beales and Watt. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Williams, James
Hurling, Chloe
Munir, Sabrina
Harley, Peter
Machado, Carolina Barcellos
Cujba, Ana-Maria
Alvarez-Fallas, Mario
Danovi, Davide
Lieberam, Ivo
Sancho, Rocio
Beales, Philip
Watt, Fiona M.
Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells
title Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells
title_full Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells
title_fullStr Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells
title_full_unstemmed Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells
title_short Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells
title_sort modelling renal defects in bardet-biedl syndrome patients using human ips cells
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272764/
https://www.ncbi.nlm.nih.gov/pubmed/37333983
http://dx.doi.org/10.3389/fcell.2023.1163825
work_keys_str_mv AT williamsjames modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT hurlingchloe modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT munirsabrina modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT harleypeter modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT machadocarolinabarcellos modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT cujbaanamaria modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT alvarezfallasmario modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT danovidavide modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT lieberamivo modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT sanchorocio modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT bealesphilip modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells
AT wattfionam modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells